Renault Group and Geely strengthen their cooperation with the completion of a partnership in Brazil
Globenewswire· 2025-11-03 14:30
合作核心内容 - 雷诺集团与吉利控股集团已签署最终协议,将战略合作扩展至巴西市场,涉及零排放和低排放汽车的生产与销售 [1] - 吉利正式收购雷诺巴西公司26.4%的股权,雷诺集团仍为控股股东并继续合并该实体报表 [2] - 此次合作旨在加速双方在巴西这一关键市场的发展,巴西占2025年上半年拉丁美洲汽车注册量的40%以上 [4] 生产与工业安排 - 吉利和雷诺品牌的汽车将在巴西圣若泽杜斯皮尼艾斯的Ayrton Senna工厂共同生产,以提高产量并增强该先进工业综合体的竞争力 [3] - 吉利将获得雷诺巴西公司工业和商业资源的使用权,以加速其在巴西市场的扩张 [2] - 雷诺将利用吉利的GEA新能源架构,为巴西市场扩展其零排放和低排放汽车产品线 [3] 商业与销售策略 - 雷诺巴西公司将在巴西分销吉利汽车的零排放和低排放汽车产品组合,为销售、金融和服务开辟新的增长机会 [4] - 吉利EX5电动SUV已通过雷诺网络运营的专属品牌经销商在巴西市场销售 [2] 合作背景与战略意义 - 此次巴西合作是双方国际战略的决定性一步,建立在工业卓越和技术领导力的基础上 [5] - 合作将使双方在快速变化的汽车市场中更具竞争力、创新性和响应速度 [5] - 双方此前已建立多个全球合作项目,包括共同投资雷诺韩国公司以及成立Horse Powertrain [5][11]
Positive phase III data for Roche’s Gazyva/Gazyvaro show significant reduction in disease activity for systemic lupus erythematosus
Globenewswire· 2025-11-03 14:00
Phase III ALLEGORY study met primary and all key secondary endpoints with Gazyva/Gazyvaro, an anti-CD20 monoclonal antibody designed for enhanced B cell depletionGazyva/Gazyvaro has the potential to be a transformative new standard of care for up to 3.4 million people affected by systemic lupus erythematosus (SLE) worldwideIf approved, Gazyva/Gazyvaro would be the first anti-CD20 therapy for SLE to directly target B cells, a key driver of inflammation and disease activity1These positive results follow the r ...
Vivoryon Therapeutics N.V. to Present at Upcoming Conferences
Globenewswire· 2025-11-03 14:00
Vivoryon Therapeutics N.V. to Present at Upcoming Conferences Halle (Saale) / Munich, Germany, November 3, 2025 - Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7) (Vivoryon), a clinical stage company developing small molecule medicines for inflammatory and fibrotic disorders, with a primary focus on kidney diseases, today announced that the Company’s management will participate in the following medical and investor conferences in November: American Society of Nephrology (ASN) Kidney Week 2 ...
IBA integrates Artificial Intelligence Quality Assurance into dosimetry solutions through the acquisition of PhantomX GmbH
Globenewswire· 2025-11-03 14:00
Dosimetry portfolio strengthened with Medical Imaging QA and AI validation Louvain-la-Neuve, Belgium, 03 November 2025 - IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and a world-leading provider of quality assurance (QA) solutions, today announces the acquisition of PhantomX GmbH, expanding IBA’s portfolio in healthcare diagnostics and therapeutic systems enabling artificial intelligence (AI) quality assurance. Founded in 2018 by Dr. Paul Jahnke and Dr. Fe ...
Molecular Partners to present updated data from Phase 1/2a trial of MP0533 in AML at ASH Annual Meeting
Globenewswire· 2025-11-03 14:00
ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin therapeutics (“Molecular Partners” or the “Company”), today announced it will present updated data from a Phase 1/2a trial of MP0533, a novel, multispecific T cell engager for acute myeloid leukemia (AML) patients, in a poster at the ...
Corbion reports the progress of its share buyback program 27 October – 31 October 2025
Globenewswire· 2025-11-03 14:00
Corbion hereby reports the transaction details related to its share buyback program announced on 1 September 2025. During the week of 27 October up to and including 31 October 2025 a total of 102.003 shares were repurchased at an average price of €17.6450 for a total amount of €1,799,838.05 To date, the total consideration for shares repurchased amounts to 420,203 shares representing 72.40% of the overall share buyback program. Corbion publishes on a weekly basis every Monday, an overview of the progress of ...
Ensurge and Corning announce collaboration to advance solid-state microbattery technology
Globenewswire· 2025-11-03 13:01
合作概述 - Ensurge与康宁公司宣布达成一系列协议 共同开发Ensurge的超高性能固态微型电池 [1] - 协议为两家公司整合康宁的Ribbon Ceramic材料及工艺技术与Ensurge成熟的固态微型电池架构建立了框架 [2] - 合作旨在推出超高能量密度的产品线扩展 以商业化用于消费电子、医疗、工业和国防领域的大批量应用的电池 [2] 合作战略意义 - 合作代表了Ensurge的一个重要战略里程碑 [3] - 将康宁的材料科学领导力应用于Ensurge的固态微型电池平台 为下一代智能设备的变革性进步奠定基础 [3] - 两家公司共同致力于卓越的创新和制造 [3] Ensurge公司背景 - 公司是固态微型电池技术领域的全球领导者 总部位于加利福尼亚州圣何塞 [1][4] - 公司拥有世界一流的专家团队 开创了在高精度卷对卷生产线上生产的薄膜电池 [4] - 其创新技术为消费电子、医疗和工业市场中受外形尺寸限制的应用带来了新的可能性 [4] - 公司与全球领先客户合作 加速其人工智能驱动产品上市 并在奥斯陆证券交易所上市 [4] 康宁公司背景 - 康宁公司是材料科学领域的世界领先创新者之一 拥有170年的历史 [5] - 公司在玻璃科学、陶瓷科学和光学物理方面拥有无与伦比的专长 并具备深厚的制造和工程能力 [5] - 公司通过持续研发投资 材料与工艺创新的独特组合 以及与行业全球领先客户的深度信任关系取得成功 [5] - 其市场涵盖光通信、移动消费电子、显示、汽车、太阳能、半导体和生命科学 [5]
Ensurge Micropower ASA – Joint development and investment agreements with Corning Incorporated to advance solid-state microbattery technology
Globenewswire· 2025-11-03 13:00
Oslo, Norway, 3 November 2025 Ensurge Micropower ASA ("Ensurge" or the "Company") today announces that the Company has entered into a set of agreements with Corning Incorporated (“Corning”), one of the world’s leading innovators in glass, ceramics, and materials science, to jointly develop ultra-high performance solid-state microbatteries based on Ensurge’s platform. Ensurge and Corning have entered into a joint development agreement to establish a framework and joint development program for the two compan ...
Faraday Future Appoints Chris Nixon Cox as Global Strategic Advisor to Accelerate Global Expansion of “EAI + Crypto” Strategy
Globenewswire· 2025-11-03 10:24
公司战略与人事任命 - 法拉第未来宣布与理查德·尼克松基金会董事、美国第37任总统理查德·尼克松的孙子Chris Nixon Cox达成全球战略顾问协议 [1] - Chris Nixon Cox将担任全球投资者关系、政府事务和产业合作的高级顾问,以支持公司加速国际化部署“EAI + Crypto”双飞轮双桥战略 [1] - 在该职位上,Chris Nixon Cox将为公司引荐潜在全球战略投资者、加强政府沟通并扩大跨境产业合作 [2] - Chris Nixon Cox还将加入公司计划成立的FFAI全球战略顾问委员会 [2][11] 战略重点与高管观点 - 公司创始人兼全球首席执行官YT Jia表示,加速“EAI + Crypto”双飞轮双桥战略的全球部署是当前的重中之重,加强顶级投资者渠道、政府关系和国际产业合作至关重要 [3] - Chris Nixon Cox认为其在全球资本市场和可持续技术方面的经验有助于推动公司在此关键阶段的战略增长 [3] - YT Jia指出,Chris Nixon Cox在资本市场、公共政策和监管事务方面的跨行业影响力与专业知识,对公司国际扩张和AI驱动转型的拐点极具价值 [3] 公司背景与业务介绍 - 法拉第未来是一家总部位于加利福尼亚的全球共享智能电动移动生态系统公司 [5] - 公司成立于2014年,旨在通过打造以用户为中心、技术优先的智能驾驶体验来颠覆汽车行业 [5] - 公司旗舰车型FF91体现了其对豪华、创新和性能的愿景 [5] - 公司的FX战略旨在推出配备与FF91类似先进豪华技术的大规模生产车型,以中低价格区间瞄准更广阔的市场 [5]
HERE Technologies 与高德达成战略合作,携手为全球中国车企提供下一代AI导航解决方案
Globenewswire· 2025-11-03 09:00
HERE Technologies 与高德达成战略合作,携手为全球中国车企提供下一代AI导航解决方案 HERE Technologies 与高德达成战略合作,携手为全球中国车企提供下一代AI导航解决方案 HERE Technologies与 高德强强联合,旨在为进军全球市场的中国电动汽车量身定制下一代导航、数字座舱及辅助驾驶解决方案。此次战略合作融合HERE全球级AI地图制图技术与高德在中国汽车行业广泛应用的领先的解决方案。 领先的位置数据与技术平台 HERE Technologies 与中国领先的导航提供商、阿里巴巴集团旗下子公司高德今日共同宣布达成战略合作,将为中国汽车品牌联合开发先进的、AI驱动导航及数字座舱解决方案。 目前,已有超过2.22亿辆汽车搭载了HERE的服务。HERE的地图与位置服务覆盖全球200多个国家和地区,具备软件定义汽车(SDV)全球部署所必需的规模、精度和可靠性。此次合作将借助HERE尖端的AI地图制图技术和高德在中国汽车生态系统的深厚积淀,加速SDV在全球的推广。 支持中国汽车厂商创新与全球扩张 高德是中国汽车导航市场的领先供应商。随着中国汽车制造商重新定义数字驾驶体 ...